PO-1071: Prognostic value of CA19-9 in patients with pancreatic adenocarcinoma after chemoradiotherapy

Autor:	Y. Nampei, Y. Toyomasu, S. Ochiai, T. Mase, Y. Watanabe, T. Kawamura, A. Takada, Y. Yamashita, N. Ii, H. Sakuma, Y. Nomoto
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Hematology medicine.disease Gastroenterology Oncology Internal medicine medicine Adenocarcinoma Radiology Nuclear Medicine and imaging CA19-9 In patient business Value (mathematics) Chemoradiotherapy
Zdroj:	Radiotherapy and Oncology. 152:S568-S569
ISSN:	0167-8140
DOI:	10.1016/s0167-8140(21)01088-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b5cea5488617f8992d3ff0f8a2eb0e33 https://doi.org/10.1016/s0167-8140(21)01088-4 Zobrazit plný text záznamu Full Text from ScienceDirect